ARCHIVES

Centocor Withdraws Yondelis After FDA Calls for New Study

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel

November 26, 1999

NCCR Calls For 15% Increase In NIH Budget, “Investment Priority”

February 11, 1994

Seer Gets Concept Approve For Five More Years From Ad Hoc Committee Since Two PLs Are DCPC Board Members

February 3, 1984

Herberman Outlines NSABP restructuring In Plan To NCI

May 6, 1994

Raising NIH Appropriations Is High Priority, House Subcommittee Chairman Says

March 7, 1997

In Brief: Weiner Elected President-Elect of AACI

February 15, 2013